Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
Wyles
David L
DL
D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology*; D006801:Humans
D044966:Anti-Retroviral Agents